Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Conditions:   Parenteral Nutrition Associated Liver Disease;   Essential Fatty Acid Deficiency;   Neurocognitive Deficit;   Malnutrition;   Pediatric ALL Intervention:   Drug: Omegaven® (fish oil triglycerides) Injectable Emulsion Sponsor:   Fresenius Kabi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2021 Category: Research Source Type: clinical trials